Zolgensma

$150.00 (USD)

0 Reviews

  

Published By Sun Pharmaceuticals Ltd

Buy Now

•  LocationUnited States
•  StatusIn stock
•  TypeNew

Zolgensma is indicated for the treatment of: patients with 5q spinal muscular atrophy (SMA) with a bi-allelic mutation in the SMN1 gene and a clinical diagnosis of SMA Type 1, or. patients with 5q SMA with a bi-allelic mutation in the SMN1 gene and up to 3 copies of the SMN2 gene.
Contact Us for more inquires and/or orders.....